Labeling for Several HCV Drugs Updated With New Drug Interactions - Hallo friendsTHE LEK NEWS, In the article you read this time with the title Labeling for Several HCV Drugs Updated With New Drug Interactions, We have prepared this article for you to read and retrieve information therein. Hopefully the contents of postings Article culture, Article economy, Article health, Article healthy tips, Article news, Article politics, Article sports, We write this you can understand. Alright, good read.

Title : Labeling for Several HCV Drugs Updated With New Drug Interactions
link : Labeling for Several HCV Drugs Updated With New Drug Interactions

Labeling for Several HCV Drugs Updated With New Drug Interactions

Review

Labeling for Several HCV Drugs Updated With New Drug Interactions
Specifically, the prescribing information for Viekira Pak (ombitasvir, paritaprevir, ritonavir, with dasabuvir; AbbVie), Viekira XR (dasabuvir, ombitasvir, paritaprevir, ritonavir; AbbVie), Technivie (ombitasvir, paritaprevir, ritonavir; AbbVie), Sovaldi (sofosbuvir; Gilead), Harvoni (ledipasvir, sofosbuvir; Gilead), Epclusa (sofosbuvir, velpatasvir; Gilead), Vosevi (sofosbuvir, velpatasvir, voxilaprevir; Gilead), Olysio (simeprevir; Janssen), Daklinza (daclatasvir; Bristol-Myers Squibb), and Zepatier (elbasvir, grazoprevir; Merck) has been updated to include information pertaining to changes in International Normalized Ratio (INR) values in patients receiving warfarin. Fluctuations in INR values may occur in patients receiving warfarin concomitant with HCV treatment. 

Read more..... http://ift.tt/2hx0ctu

Thus Article Labeling for Several HCV Drugs Updated With New Drug Interactions

That's an article Labeling for Several HCV Drugs Updated With New Drug Interactions This time, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article Labeling for Several HCV Drugs Updated With New Drug Interactions with the link address https://theleknews.blogspot.com/2017/11/labeling-for-several-hcv-drugs-updated.html

Tweet

Subscribe to receive free email updates: